Topic: How To Invest

Q: Thanks for your ongoing advice, Pat. What do you think about women-centric Eve & Co. as a speculative cannabis stock? Thanks again.

Article Excerpt

A: Eve & Co., $0.45, symbol EVE on the Toronto Venture Exchange (Shares outstanding: 248.1 million; Market cap: $111.6 million; www.evecannabis.ca), through its wholly owned subsidiary Natural MedCo Ltd., holds cultivation and processing licenses under the Cannabis Act (Canada) for the production and sale of various cannabis products, including dried cannabis, cannabis plants and cannabis oil. The stock began trading in July 2018. Natural MedCo Ltd. was Canada’s first female-founded licensed producer of medicinal marijuana and received its cultivation license from Health Canada in 2016. Currently, two-thirds of the company’s 63 employees are women, including three-quarters of its management team. The company has supply agreements with B.C., Newfoundland, and Ontario as well as an agreement to export its products to Germany. In July 2018, Eve & Co completed construction of a 220,000-square-foot greenhouse production facility located in Strathroy, Ontario, with production capacity of around 10,000 kilograms per year. Soon after, the company commenced construction of a 780,000 square foot expansion. It should be completed later…

You are trying to access subscriber-only content.

To read this article, you may subscribe or sign in.
If you are already a subscriber, log in here.

If you wish to become a subscriber, click here. Or you may enjoy access to all our publications when you become a Member of Pat McKeough's Inner Circle Pro.